Brainify.AI Company
AI/ML EEG biomarker platform for novel treatment development for depression in women, which increases the likelihood of new drug approval.
Founded Date:
2021-02-27
Last Funding Type:
Pre-Seed
Headquarters:
New York, New York, United States
Technology:
['BioTech & HealthTech']
Employee Number:
11-50
Industry:
NeuroTech
Last Funding Date:
2023-01-10
Funding Status:
Seed
Investor Type:
info@brainify.ai
Total Funding:
1600000